BGAI
AMPH icon

Bruce G. Allen Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bruce G. Allen Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$261 – 1084
2025
Q1 		$261 Hold
9
– – ﹤0.01% 1032
2024
Q4 		$334 Buy
+9
New +$412 ﹤0.01% 1017

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bruce G. Allen Investments's AMPH Position: Q2 2025 in Review

Bruce G. Allen Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 9 shares — an estimated $261 sold.

Bruce G. Allen Investments first reported a position in AMPH in Q4 2024 and held it in 2 quarters. The position peaked at $334 in Q4 2024. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • Bruce G. Allen Investments reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Bruce G. Allen Investments sold 9 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $261.
  • Bruce G. Allen Investments first reported a position in Amphastar Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Bruce G. Allen Investments's Amphastar Pharmaceuticals position peaked at $334 in Q4 2024.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on Bruce G. Allen Investments's 13F filing for Q2 2025, filed 9 Jul 2025.